Neubase Therapeutics Stock Filter Stocks by Fundamentals

NBSE Stock  USD 0.45  0.02  4.65%   
NeuBase Therapeutics fundamentals help investors to digest information that contributes to NeuBase Therapeutics' financial success or failures. It also enables traders to predict the movement of NeuBase Stock. The fundamental analysis module provides a way to measure NeuBase Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuBase Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

NeuBase Price to Earning Analysis

NeuBase Price to Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for NeuBase Therapeutics is extremely important. It helps to project a fair market value of NeuBase Stock properly, considering its historical fundamentals such as Price to Earning. Since NeuBase Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NeuBase Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NeuBase Therapeutics' interrelated accounts and indicators.
0.450.93-0.93-0.44-0.40.450.270.680.760.940.59-0.41-0.410.58-0.060.8-0.270.170.60.560.70.73-0.25-0.370.58
0.450.47-0.2-0.33-0.570.320.190.380.250.14-0.1-0.34-0.34-0.050.64-0.110.420.27-0.12-0.160.07-0.150.020.36-0.19
0.930.47-0.91-0.32-0.490.350.350.520.530.860.33-0.38-0.380.620.090.75-0.110.340.350.420.670.660.08-0.220.43
-0.93-0.2-0.910.210.38-0.37-0.22-0.47-0.6-0.98-0.480.360.36-0.680.19-0.910.39-0.21-0.52-0.59-0.79-0.850.130.49-0.59
-0.44-0.33-0.320.210.18-0.53-0.35-0.93-0.57-0.3-0.510.490.49-0.020.02-0.07-0.22-0.23-0.47-0.310.01-0.150.240.11-0.39
-0.4-0.57-0.490.380.18-0.71-0.49-0.26-0.1-0.290.130.80.8-0.23-0.51-0.16-0.2-0.260.10.05-0.28-0.13-0.18-0.180.06
0.450.320.35-0.37-0.53-0.710.580.630.460.40.35-0.97-0.970.040.10.21-0.120.140.340.320.070.21-0.34-0.330.32
0.270.190.35-0.22-0.35-0.490.580.370.270.240.21-0.59-0.590.020.060.18-0.070.080.20.430.020.150.05-0.170.41
0.680.380.52-0.47-0.93-0.260.630.370.750.560.67-0.54-0.540.17-0.050.330.030.170.640.460.230.37-0.45-0.250.55
0.760.250.53-0.6-0.57-0.10.460.270.750.740.93-0.33-0.330.33-0.360.62-0.54-0.270.920.780.50.66-0.57-0.550.8
0.940.140.86-0.98-0.3-0.290.40.240.560.740.67-0.36-0.350.67-0.310.94-0.50.070.690.710.790.9-0.26-0.570.72
0.59-0.10.33-0.48-0.510.130.350.210.670.930.67-0.21-0.20.32-0.590.63-0.65-0.380.990.830.440.68-0.61-0.650.87
-0.41-0.34-0.380.360.490.8-0.97-0.59-0.54-0.33-0.36-0.211.0-0.07-0.19-0.180.03-0.24-0.2-0.23-0.05-0.170.10.24-0.21
-0.41-0.34-0.380.360.490.8-0.97-0.59-0.54-0.33-0.35-0.21.0-0.07-0.19-0.170.02-0.24-0.19-0.23-0.04-0.170.10.24-0.21
0.58-0.050.62-0.68-0.02-0.230.040.020.170.330.670.32-0.07-0.07-0.210.72-0.230.170.370.310.830.780.1-0.190.29
-0.060.640.090.190.02-0.510.10.06-0.05-0.36-0.31-0.59-0.19-0.19-0.21-0.440.690.3-0.58-0.65-0.22-0.530.290.72-0.63
0.8-0.110.75-0.91-0.07-0.160.210.180.330.620.940.63-0.18-0.170.72-0.44-0.63-0.080.680.70.830.93-0.17-0.570.73
-0.270.42-0.110.39-0.22-0.2-0.12-0.070.03-0.54-0.5-0.650.030.02-0.230.69-0.630.57-0.67-0.76-0.38-0.640.370.81-0.71
0.170.270.34-0.21-0.23-0.260.140.080.17-0.270.07-0.38-0.24-0.240.170.3-0.080.57-0.42-0.26-0.12-0.120.340.09-0.38
0.6-0.120.35-0.52-0.470.10.340.20.640.920.690.99-0.2-0.190.37-0.580.68-0.67-0.420.830.50.72-0.59-0.630.88
0.56-0.160.42-0.59-0.310.050.320.430.460.780.710.83-0.23-0.230.31-0.650.7-0.76-0.260.830.460.76-0.32-0.820.93
0.70.070.67-0.790.01-0.280.070.020.230.50.790.44-0.05-0.040.83-0.220.83-0.38-0.120.50.460.88-0.12-0.220.52
0.73-0.150.66-0.85-0.15-0.130.210.150.370.660.90.68-0.17-0.170.78-0.530.93-0.64-0.120.720.760.88-0.21-0.610.78
-0.250.020.080.130.24-0.18-0.340.05-0.45-0.57-0.26-0.610.10.10.10.29-0.170.370.34-0.59-0.32-0.12-0.210.4-0.44
-0.370.36-0.220.490.11-0.18-0.33-0.17-0.25-0.55-0.57-0.650.240.24-0.190.72-0.570.810.09-0.63-0.82-0.22-0.610.4-0.71
0.58-0.190.43-0.59-0.390.060.320.410.550.80.720.87-0.21-0.210.29-0.630.73-0.71-0.380.880.930.520.78-0.44-0.71
Click cells to compare fundamentals
Competition

NeuBase Retained Earnings

Retained Earnings

(87.85 Million)

At present, NeuBase Therapeutics' Retained Earnings are projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, the price to earning indicator of NeuBase Therapeutics is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Earning (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

NeuBase Fundamentals

About NeuBase Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NeuBase Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuBase Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuBase Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. Neu Base operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 33 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NeuBase Therapeutics is a strong investment it is important to analyze NeuBase Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeuBase Therapeutics' future performance. For an informed investment choice regarding NeuBase Stock, refer to the following important reports:
Check out NeuBase Therapeutics Piotroski F Score and NeuBase Therapeutics Altman Z Score analysis.
For information on how to trade NeuBase Stock refer to our How to Trade NeuBase Stock guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for NeuBase Stock analysis

When running NeuBase Therapeutics' price analysis, check to measure NeuBase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuBase Therapeutics is operating at the current time. Most of NeuBase Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuBase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuBase Therapeutics' price. Additionally, you may evaluate how the addition of NeuBase Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is NeuBase Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuBase Therapeutics. If investors know NeuBase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuBase Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(18.60)
Return On Assets
(0.43)
Return On Equity
(0.93)
The market value of NeuBase Therapeutics is measured differently than its book value, which is the value of NeuBase that is recorded on the company's balance sheet. Investors also form their own opinion of NeuBase Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is NeuBase Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuBase Therapeutics' market value can be influenced by many factors that don't directly affect NeuBase Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuBase Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuBase Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuBase Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.